Alzheimer's (Type 3 Diabetes)
-
I forbindelse med JP Morgans Healthcare konference tilbage i januar maaned kom CSO hos Novo Nordisk (Mads Krogsgaard Thomsen ) til at naevne, at liraglutid maaske (maaske ikke) virker mod Alzheimer's; noget som har vaeret oppe at vende flere gange i det forrige aarti. Ifm deres Q4-telekonference blev der (desvaerre) stillet rigtig mange spoergsmaal til dette:
https://seekingalpha.com/article/4321616-novo-nordisk-s-nvo-ceo-lars-fruergaard-jorgensen-on-q4-2019-results-earnings-call-transcript?part=singleHvorom alting er, saa undersoegte jeg Alzheimers/Parkinson-landskabet en lille smule af ren nysgerrighed og vil blot dele et par link, som jeg stoedte paa undervejs.
2019 - Alzheimer's disease drug development pipeline: 2019
https://www.ncbi.nlm.nih.gov/pubmed/313343302008 - Alzheimer's Disease Is Type 3 Diabetes
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769828/2020 - Could an NLRP3 inhibitor be the one drug to conquer common diseases?
https://cen.acs.org/pharmaceuticals/drug-discovery/Could-an-NLRP3-inhibitor-be-the-one-drug-to-conquer-common-diseases/98/i7Biogen (Aducanumab):
https://www.biogen.com/en_us/pipeline.html
"Buffett's a believer: Berkshire bets $192M on Biogen ahead of key Alzheimer's filing"
https://www.fiercepharma.com/pharma/a-192m-moat-buffett-s-berkshire-builds-stake-biogen-ahead-key-alzheimer-s-drug-filingAgenebio:
https://www.agenebio.com/pipeline/agb101-for-amnestic-mild-cognitive-impairment-amci/
"AGB101 is in development to treat mild cognitive impairment due to Alzheimer's disease (MCI due to AD) and to delay progression to Alzheimer's dementia."Biohaven (BHV4157-203 / Troriluzole):
https://www.biohavenpharma.com/science-pipeline/our-pipelineCortexyme (COR388):
https://www.cortexyme.com/?page_id=6022Anavex (Anavex 2-73):
https://www.anavex.com/IFM Therapeutics:
https://www.ifmthera.com/pipeline/
2019-04-01
Novartis adds clinical and preclinical anti-inflammatory programs to portfolio with acquisition of IFM Tre
https://www.novartis.com/news/media-releases/novartis-adds-clinical-and-preclinical-anti-inflammatory-programs-portfolio-acquisition-ifm-treInflazome:
http://inflazome.com/pipeline.htmlNodthera:
https://www.nodthera.com/why-nrlp3/Lundbeck:
https://www.lundbeck.com/global/brain-disorders/pipeline
-
Problemer med figurerne...
-
1000 tak Tommy for at dele resultater af din research med os andre.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind